These CAF-related molecules further confer the aggressiveness of ovarian cancer cells through the activation of NF-κB signaling pathway and the up-regulation of CD44, MMP9 and hyaluronan-mediated motility receptor (HMMR) [40]. The gene discussed is CD44; the disease is ovarian carcinoma.